TNNT2 and diabetes mellitus: Detection of cardiomyocyte injury, particularly when identified using a high sensitivity assay (e.g., hs-cTnT), has an important role for prognosticating HF onset, hospitalization [85, 86], and all-cause and CV mortality [87] of patients with diabetes [85].